government regulation

Summary

Summary: Exercise of governmental authority to control conduct.

Top Publications

  1. ncbi FDA regulation of stem-cell-based therapies
    Dina Gould Halme
    School of Medicine, University of California at San Francisco, San Francisco, USA
    N Engl J Med 355:1730-5. 2006
  2. ncbi Understanding Philip Morris's pursuit of US government regulation of tobacco
    P A McDaniel
    Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143 1390, USA
    Tob Control 14:193-200. 2005
  3. ncbi Decline in hospitalisations due to dog bite injuries in Catalonia, 1997-2008. An effect of government regulation?
    Joan R Villalbí
    Agència de Salut Pública de Barcelona, Barcelona, Spain
    Inj Prev 16:408-10. 2010
  4. ncbi Scientific and legal perspectives on science generated for regulatory activities
    Carol J Henry
    American Chemistry Council, Arlington, Virginia, USA
    Environ Health Perspect 116:136-41. 2008
  5. ncbi Naturally occurring asbestos: a recurring public policy challenge
    R J Lee
    RJ Lee Group Inc, Monroeville, PA 15146, USA
    J Hazard Mater 153:1-21. 2008
  6. ncbi Government regulation of sex and sexuality: in their own words
    Sofia Gruskin
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
    Reprod Health Matters 17:108-18. 2009
  7. ncbi Ambient air pollution: health hazards to children
    Janice J Kim
    Pediatrics 114:1699-707. 2004
  8. ncbi Modern regulatory impact analysis: the experience of the European Union
    Bruce Ballantine
    Business Decisions Limited, Heronswood House, Maidstone Road, Pembury, Kent TN2 4DD, UK
    Regul Toxicol Pharmacol 44:57-68. 2006
  9. ncbi Organophosphate exposures in the United States: a longitudinal analysis of incidents reported to poison centers
    Daniel L Sudakin
    Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331 6502, USA
    J Toxicol Environ Health A 70:141-7. 2007
  10. ncbi Regulatory parallels to Daubert: stakeholder influence, "sound science," and the delayed adoption of health-protective standards
    Roni A Neff
    Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Room E6636, Baltimore, MD 21205, USA
    Am J Public Health 95:S81-91. 2005

Research Grants

  1. Trends and Trajectories of Oral Health Among Older Americans: The Role of Cognit
    Bei Wu; Fiscal Year: 2009
  2. Proxy Decision Making for Alzheimer Disease Research
    Laura Dunn; Fiscal Year: 2009
  3. Biology of Fungal Melanin
    Arturo Casadevall; Fiscal Year: 2009
  4. Youth Alcohol, Tobacco and Marijuana Use: Effects of Hours of Work and Wages
    Robert Kaestner; Fiscal Year: 2009
  5. Synergy of Host Defense Mechanisms in the Lung
    Arturo Casadevall; Fiscal Year: 2009
  6. Impact of Medicare Part D on Racial Disparities in Diabetes Treatment and Outcome
    Julie Marie Donohue; Fiscal Year: 2010
  7. Impact of Poor Health & AIDS on Small Businesses in SA
    Mark Pauly; Fiscal Year: 2003
  8. National Black Leadership Conference on Genetics
    Kathy Hudson; Fiscal Year: 2004
  9. Making Every Voice Count: Public Consultation on Genetics, Environment and Health
    Kathy Hudson; Fiscal Year: 2007
  10. Making Every Voice Count: Public Consultation on Genetics, Environment and Health
    Joan Scott; Fiscal Year: 2007

Detail Information

Publications221 found, 100 shown here

  1. ncbi FDA regulation of stem-cell-based therapies
    Dina Gould Halme
    School of Medicine, University of California at San Francisco, San Francisco, USA
    N Engl J Med 355:1730-5. 2006
  2. ncbi Understanding Philip Morris's pursuit of US government regulation of tobacco
    P A McDaniel
    Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143 1390, USA
    Tob Control 14:193-200. 2005
    ..To investigate Philip Morris's support of US Food and Drug Administration (FDA) regulation of tobacco products and analyse its relationship to the company's image enhancement strategies...
  3. ncbi Decline in hospitalisations due to dog bite injuries in Catalonia, 1997-2008. An effect of government regulation?
    Joan R Villalbí
    Agència de Salut Pública de Barcelona, Barcelona, Spain
    Inj Prev 16:408-10. 2010
    ..To analyse population-based data on hospitalisation caused by dog bite injuries after changes in legal regulations on dog ownership, including breed-specific regulations...
  4. ncbi Scientific and legal perspectives on science generated for regulatory activities
    Carol J Henry
    American Chemistry Council, Arlington, Virginia, USA
    Environ Health Perspect 116:136-41. 2008
    ..In a closely related example, the U.S. Environmental Protection Agency considered but abandoned a program to implement standards aimed at "external" information...
  5. ncbi Naturally occurring asbestos: a recurring public policy challenge
    R J Lee
    RJ Lee Group Inc, Monroeville, PA 15146, USA
    J Hazard Mater 153:1-21. 2008
    ....
  6. ncbi Government regulation of sex and sexuality: in their own words
    Sofia Gruskin
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
    Reprod Health Matters 17:108-18. 2009
    ....
  7. ncbi Ambient air pollution: health hazards to children
    Janice J Kim
    Pediatrics 114:1699-707. 2004
    ....
  8. ncbi Modern regulatory impact analysis: the experience of the European Union
    Bruce Ballantine
    Business Decisions Limited, Heronswood House, Maidstone Road, Pembury, Kent TN2 4DD, UK
    Regul Toxicol Pharmacol 44:57-68. 2006
    ..The paper finally draws a number of conclusions and makes a number of recommendations for further improvements in the quality of the regulatory process in the European Union...
  9. ncbi Organophosphate exposures in the United States: a longitudinal analysis of incidents reported to poison centers
    Daniel L Sudakin
    Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331 6502, USA
    J Toxicol Environ Health A 70:141-7. 2007
    ..The results of this investigation are consistent with other studies that have reported that regulatory restriction of access to pesticide formulations may have a significant impact on the number of human exposure incidents...
  10. ncbi Regulatory parallels to Daubert: stakeholder influence, "sound science," and the delayed adoption of health-protective standards
    Roni A Neff
    Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Room E6636, Baltimore, MD 21205, USA
    Am J Public Health 95:S81-91. 2005
    ..Most recently, political tampering with science provides the foundation for some policymakers to disregard science completely in the environmental regulatory process...
  11. ncbi Environmental pediatrics and its impact on government health policy
    Lynn Goldman
    Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 20815, USA
    Pediatrics 113:1146-57. 2004
    ..More recently, these issues have been taken up by states and in the international arena...
  12. ncbi Manufacturing uncertainty: contested science and the protection of the public's health and environment
    David Michaels
    Department of Environmental and Occupational Health, George Washington University School of Public Health and Health Services, 2100 M St NW, Suite 203, Washington, DC 20037, USA
    Am J Public Health 95:S39-48. 2005
    ..The public health system must ensure that scientific evidence is evaluated in a manner that assures the public's health and environment will be adequately protected...
  13. ncbi Learning the value of drugs--is rofecoxib a regulatory success story?
    Rebecca S Eisenberg
    University of Michigan Law School, Ann Arbor, USA
    N Engl J Med 352:1285-7. 2005
  14. ncbi Legislating "sound science": the role of the tobacco industry
    Annamaria Baba
    Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143, USA
    Am J Public Health 95:S20-7. 2005
    ..The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions...
  15. ncbi The birth of the e-clinic. Continuity or transformation in the UK governance of pharmaceutical consumption?
    Nick Fox
    ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
    Soc Sci Med 61:1474-84. 2005
    ..This continuity can be explained by Rosenau's (Along the Domestic-Foreign Frontier. Cambridge University Press, Cambridge, 1997) model of a contested and fragmenting process of technology governance...
  16. ncbi Perspectives on human stem cell research
    Kyu Won Jung
    Law School, Hanyang University, 17 Haengdang dong, Seongdong Gu, Seoul 133 791, South Korea
    J Cell Physiol 220:535-7. 2009
    ..We do not need to exclude any type of stem cell research because each has its own merits and issues, and they can facilitate the scientific revolution when working together...
  17. ncbi European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287
    David J Flavell
    Lancet 362:1415. 2003
  18. ncbi Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referral
    Sujit Choudhry
    Faculty of Law, University of Toronto, ON
    CMAJ 170:1115-8. 2004
  19. ncbi Declining sex ratio: role of society, technology and government regulation in Faridabad district, Haryana
    A Bardia
    Centre for Community Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
    Natl Med J India 17:207-11. 2004
    ..and acceptability of the practice of sex determination), technology (availability and affordability) and government regulation in the adverse ratio for girls in the Ballabgarh block of Haryana in northern India...
  20. ncbi A regulatory patchwork--human ES cell research oversight
    Lori P Knowles
    Health Law Institute, University of Alberta, Canada
    Nat Biotechnol 22:157-63. 2004
  21. ncbi Rights, patents, markets and the global AIDS pandemic
    James Thuo Gathii
    Albany Law School, USA
    Fla J Int Law 14:261-352. 2002
  22. ncbi The case for preemption of prescription drug failure-to-warn claims
    Christine H Kim
    Food Drug Law J 62:399-422. 2007
  23. ncbi A history of drug advertising: the evolving roles of consumers and consumer protection
    Julie Donohue
    University of Pittsburgh, Graduate School of Public Health, Department of Health Policy and Management, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, PA 15261, USA
    Milbank Q 84:659-99. 2006
    ....
  24. ncbi Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate
    Howard L Dorfman
    Bayer HealthCare LLC, West Haven, CT, USA
    Food Drug Law J 61:585-622. 2006
  25. ncbi A cognitive scientist looks at Daubert
    George P Lakoff
    1203 Dwinelle Hall, University of California at Berkeley, Berkeley, CA 94720 2650, USA
    Am J Public Health 95:S114-20. 2005
    ..Daubert functions in its application as a strategic initiative that significantly moves America in a conservative direction, in the moral and political spheres, as well as in the legal sphere...
  26. ncbi Diversionary reframing of the Great Lakes Water Quality Agreement
    Michael Gilbertson
    Occupational and Environmental Health Research Group, Stirling University, Scotland, UK
    J Public Health Policy 28:201-15. 2007
    ..The scientific evidence of continuing injury to health and property from trans-boundary pollution convinces us that this reframing is an unwarranted diversion from the original intent...
  27. ncbi Why Ashcroft is wrong on assisted suicide
    Nelson Lund
    George Mason University School of Law, USA
    Commentary 113:50-5. 2002
  28. ncbi The creation of industry front groups: the tobacco industry and "get government off our back"
    Dorie E Apollonio
    Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA
    Am J Public Health 97:419-27. 2007
    ..Those who seek to establish measures to protect public health should be prepared to counter the argument that government should not regulate private behavior...
  29. ncbi Philip Morris' FDA gambit: good for public health?
    Michael Givel
    Department of Political Science, The University of Oklahoma, 455 West Lindsey, Room 2I7, Norman, USA
    J Public Health Policy 26:450-68. 2005
    ..On the other hand, tobacco products would have remained a politically and economically viable and legal product consumed by millions of Americans many of whom would have continued to suffer from tobacco-related illnesses and deaths...
  30. ncbi Death at a discount: how the tobacco industry thwarted tobacco control policies in US military commissaries
    Elizabeth A Smith
    Department of Social and Behavioral Sciences, University of California, San Francisco, Box 0612 San Francisco, CA 94143 0612, USA
    Tob Control 16:38-46. 2007
    ..Tobacco use also impairs short-term troop readiness...
  31. ncbi Drug risks and free speech--can Congress ban consumer drug ads?
    Miriam Shuchman
    N Engl J Med 356:2236-9. 2007
  32. ncbi Politics, culture, and the lab: public attitudes toward animals and human embryonic stem cells have fostered different research agendas in Britain and the United States
    Anne Marie Borrego
    Chron High Educ 51:A43-5. 2005
  33. ncbi The President's Council on Bioethics: my take on some of its deliberations
    William F May
    Institute for Practical Bioethics and Public Life, University of Virginia, USA
    Perspect Biol Med 48:229-40. 2005
  34. ncbi The impact of the cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implications
    Ragnar E Lofstedt
    King s Centre for Risk Management, King s College London, London, England
    J Health Commun 12:471-91. 2007
    ....
  35. ncbi Law's knowledge: science for justice in legal settings
    Sheila Jasanoff
    John F Kennedy School of Government, School of Public Health, Department of the History of Science, Harvard University, 79 JFK Street, Room L354, Boston, MA, USA
    Am J Public Health 95:S49-58. 2005
    ..The important question for the law is not how judges can best do justice to science, but rather how courts can better render justice under conditions of uncertainty and ignorance...
  36. ncbi What has a decade of Daubert wrought?
    Margaret A Berger
    Brooklyn Law School, 250 Joralemon Street, Room 911, Brooklyn, NY 11201, USA
    Am J Public Health 95:S59-65. 2005
    ..expert witnesses? What do we know about Daubert's impact on improving science in the court room? What has been Daubert's effect on access to the courts? Does Daubert further public policy objectives of protecting the public against harm?..
  37. ncbi Ten years of judicial gatekeeping under Daubert
    Joe S Cecil
    Federal Judicial Center s Program on Scientific and Technical Evidence, One Columbus Circle, NE, Washington, DC 20002, USA
    Am J Public Health 95:S74-80. 2005
    ..Future research should focus on the pretrial screening of expert testimony and interactions between the attorneys and experts in shaping that testimony...
  38. ncbi From Asilomar to industrial biotechnology: risks, reductionism and regulation
    Sheldon Krimsky
    Department of Urban and Environmental Policy and Planning, Tufts University, Medford, MA 02155, USA
    Sci Cult (Lond) 14:309-23. 2005
  39. ncbi Neoliberal and public health effects of failing to adopt OSHA's national secondhand tobacco smoke rule
    Michael Givel
    Department of Political Science, The University of Oklahoma, Norman 73109, USA
    Int J Health Serv 36:137-55. 2006
    ....
  40. ncbi The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations
    Finnuala Kelleher
    Columbia Journal of Law and Social Problems, Columbia University, USA
    Columbia J Law Soc Probl 38:67-106. 2004
    ....
  41. ncbi Ethics and policy perspectives on personalized medicine in the post-genomic era
    Melissa R Landon
    Boston University, USA
    J Biolaw Bus 8:28-36. 2005
    ....
  42. ncbi Obesity--the new frontier of public health law
    Michelle M Mello
    Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
    N Engl J Med 354:2601-10. 2006
  43. ncbi Legal developments relevant to FDA authority
    Daniel Meron
    Department of Health and Human Services, USA
    Food Drug Law J 62:441-4. 2007
  44. ncbi Daubert's menace
    Gio Batta Gori
    Am J Public Health 96:206; discussion 206-7. 2006
  45. ncbi Public health. A case study of personalized medicine
    S H Katsanis
    Genetics and Public Policy Center, Berman Institute of Bioethics [corrected, The Johns Hopkins University, Washington, DC 20036, USA
    Science 320:53-4. 2008
  46. ncbi Privacy and policy for genetic research
    Judith Wagner DeCew
    Department of Philosophy, Clark University, 950 Main Street, Worcester, MA 01610, USA
    Ethics Inf Technol 6:5-14. 2004
    ....
  47. ncbi New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation
    Susan Chimonas
    Center on Medicine as a Profession (CMAP, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Health Aff (Millwood) 24:949-60. 2005
    ..We also explore the implications--some intended, others unanticipated--of the final document...
  48. ncbi Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit
    David Wendler
    Department of Clinical Bioethics, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
    JAMA 294:826-32. 2005
    ..These data also raise the question of whether the federal minimal risk standard may sometimes fail to provide sufficient protection for children, prompting the need to consider alternative standards...
  49. ncbi The perils of relying on interested parties to evaluate scientific quality
    Wendy Wagner
    University of Texas School of Law, 727 East Dean Keeton Street, Austin, TX 78705 3299, USA
    Am J Public Health 95:S99-106. 2005
    ....
  50. ncbi Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation
    Christopher D Zalesky
    World Wide Health Care Compliance, Johnson and Johnson, USA
    J Health Law 39:235-64. 2006
    ..This approach borrows lessons learned from the FDA's efficient and effective regulatory and enforcement methods and maintains a careful balance between the interests of patient-beneficiaries, the government and industry...
  51. ncbi A postmodernist take on the human embryo research debate
    Lars Noah
    University of Florida, USA
    Conn Law Rev 36:1133-61. 2004
  52. ncbi Ethics, regulation, and biomedical research
    Matthew Weed
    Yale University, USA
    Kennedy Inst Ethics J 14:361-8. 2004
    ....
  53. ncbi Protecting research subjects--the crisis at Johns Hopkins
    Robert Steinbrook
    N Engl J Med 346:716-20. 2002
  54. ncbi Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs
    Lars Noah
    University of Florida, P O Box 117625, Gainesville, FL 32611 7625, USA
    S C Law Rev 54:371-403. 2002
    ..Otherwise, patients may continue to lose access to important therapeutic products...
  55. ncbi Human research protections: time for regulatory reform?
    Karen J Maschke
    Hastings Cent Rep 38:19-22. 2008
  56. ncbi Children in clinical research: a conflict of moral values
    Vera Hassner Sharav
    The Alliance for Human Research Protection
    Am J Bioeth 3:W-IF 2. 2003
    ....
  57. ncbi A comprehensive national policy to stop human cloning: an analysis of the Human Cloning Prohibition Act of 2001 with recommendations for federal and state legislatures
    Shawn E Peterson
    Notre Dame Law School, USA
    Notre Dame J Law Ethics Public Policy 17:217-68. 2003
  58. ncbi Experts warn drug industry, government about weaknesses in drug supply chain
    Donna Young
    Am J Health Syst Pharm 60:2176, 2180, 2184. 2003
  59. ncbi Private wealth and public health: a critique of Richard Epstein's defense of the "old" public health
    William J Novak
    Department of History, University of Chicago, 1126 East 59th Street, Chicago, IL 60637, USA
    Perspect Biol Med 46:S176-98. 2003
    ....
  60. ncbi Cloning and stem cells--handicapping the political and scientific debates
    George Q Daley
    Whitehead Institute for Biomedical Research, Cambridge, USA
    N Engl J Med 349:211-2. 2003
  61. ncbi The need for FDA regulation of tobacco products
    Edward M Kennedy
    Yale J Health Policy Law Ethics 3:101-8. 2002
  62. ncbi Clinical trials face heightened scrutiny as science and commerce appear to merge
    Alvin J Lorman
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, USA
    J Biolaw Bus 4:23-32. 2001
    ..The risk of increased government involvement includes criminal prosecution of physicians for failing to follow the rules, as an innovative case in California demonstrates...
  63. ncbi Molecular diagnostics: an FDA perspective
    Ali M Ardekani
    Department of Therapeutic Proteins, CBER, FDA, Bethesda, MD 20892, USA
    Expert Rev Mol Diagn 3:129-40. 2003
    ....
  64. ncbi Informed consent and investigational new drug abuses in the U.S. military
    Mary L Cummings
    Systems Engineering, University of Virginia, PO Box 400747, Charlottesville, VA 22904 4747, USA
    Account Res 9:93-103. 2002
    ....
  65. ncbi America's other drug problem: how the drug industry distorts medicine and politics
    Arnold S Relman
    Harvard Medical School, USA
    New Repub 227:27-41. 2002
  66. ncbi The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly
    David C Vladeck
    Georgetown University Law Center Center of Health Regulation and Governance of the O Neill Institute for National and Global Health Law Institute for Public Representation and Center for Progressive Reform, USA
    Cornell Law Rev 93:981-1002. 2008
  67. ncbi Pharmacogenetics: ethical issues and policy options
    Allen Buchanan
    Department of Philosophy, University of Arizona, Tucson, AZ, USA
    Kennedy Inst Ethics J 12:1-15. 2002
    ..We analyze each of these categories of ethical issues and provide policy approaches for addressing them...
  68. ncbi Liability for institutional review boards: from regulation to litigation
    David B Resnik
    The Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA
    J Leg Med 25:131-84. 2004
  69. ncbi Taking another look at the definition of an embryo: President Bush's criteria and the problematic application of federal regulations to human embryonic stem cells
    Simon B Auerbach
    Emory University School of Law, Atlanta, Georgia, USA
    Emory Law J 51:1557-604. 2002
  70. ncbi Dipping into Uncle Sam's pockets: federal funding of stem cell research: is it legal?
    Carly Goldstein
    Boston Univ Public Interest Law J 11:229-59. 2002
  71. ncbi The federal preemption debate in pharmaceutical labeling product liability actions
    Jodie M Gross
    Harris Beach PLLC, New York, New York, USA
    Tort Trial Insur Pract Law J 43:35-70. 2007
  72. ncbi Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007
    Daniel Meron
    United States Department of Health and Human Services, USA
    Seton Hall Law Rev 37:929-39. 2007
  73. ncbi FDA and EMEA pool scientific advice
    Alla Katsnelson
    Nat Biotechnol 22:1490-1. 2004
  74. ncbi Bioethical malpractice: risk and responsibilities in human research
    Barbara A Noah
    Health Law and Policy, University of Florida Levin College of Law, P.O. Box 117629, Gainesville, FL 32611-7629, USA
    J Health Care Law Policy 7:175-241. 2004
  75. ncbi Reflections of a forensic psychiatrist in Washington: politics and policy
    Renee L Binder
    Psychiatry and the Law Program, University of California, San Francisco, CA, USA
    J Am Acad Psychiatry Law 32:324-8. 2004
  76. ncbi Liberalism, communitarianism, and public health: comments on Lawrence O. Gostin's lecture
    Wendy E Parmet
    Northeastern University, USA
    Fla Law Rev 55:1221-40. 2003
  77. ncbi Puppy love: bioterrorism, civil rights, and public health
    George J Annas
    Health Law Department, Boston University School of Public Health, USA
    Fla Law Rev 55:1171-90. 2003
  78. ncbi When terrorism threatens health: how far are limitations on personal and economic liberties justified?
    Lawrence O Gostin
    Georgetown Univesity, Washington, DC, USA
    Fla Law Rev 55:1105-70. 2003
  79. ncbi Nontherapeutic research with children: the virtues and vices of legal uncertainty
    David M Smolin
    Cumberland Law School, Samford University, USA
    Cumberland Law Rev 33:621-45. 2002
  80. ncbi Bush tails follow-ons
    Jeff Fox
    Nat Biotechnol 26:366. 2008
  81. ncbi Senators grill NIH director over restrictions on stem-cell research
    Jeffrey Brainard
    Chron High Educ 49:A25. 2003
  82. ncbi The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902
    David E Lilienfeld
    Perspect Biol Med 51:188-98. 2008
    ..That power, welcomed by manufacturers to restore the public's trust in their products, was enhanced in the 1906 Food and Drug Act, which created the Food and Drug Administration...
  83. ncbi Safety in New Zealand's adventure tourism industry: the client accident experience of adventure tourism operators
    T A Bentley
    Centre for Tourism Research, Department of Management and International Business, Massey University, Albany, New Zealand
    J Travel Med 7:239-45. 2000
    ..CONCLUSIONS: The prevalence of client injuries in activity sectors not presently covered by government regulation, suggests policy makers should look again at extending codes of practice to a wider range of adventure ..
  84. ncbi Is there a need for professional regulation for primary care mental health workers?
    Soo Lee
    School of Social Community and Health Studies, University of Hertfordshire, Hatfield, Herts, UK
    Qual Prim Care 16:263-7. 2008
    ..This paper argues that professional regulation is not needed as there are other systems with similar significance that promote quality of care and can offer protection to the public...
  85. ncbi [Tuberculosis vaccination programs: where are we?]
    C Manaouil
    Consultation de médecine légale, CHU d Amiens, Place Victor Pauchet, 80054 Amiens Cedex 1, France
    Arch Pediatr 15:1100-6. 2008
    ..In parallel, a national programme of fight against tuberculosis 2007-2009 is launched...
  86. ncbi MotherNature: establishing a Canadian research network for natural health products (NHPs) during pregnancy and lactation
    Gideon Koren
    Motherisk Program, Hospital for Sick Children, Toronto, Ontario, Canada
    J Altern Complement Med 14:369-72. 2008
    ....
  87. ncbi Alberta to limit self-regulation
    Deborah Jones
    CMAJ 177:1342. 2007
  88. ncbi Is the metaphor of 'barriers to change' useful in understanding implementation? Evidence from general medical practice
    Kath Checkland
    National Primary Care Research and Development Centre, University of Manchester, Manchester, UK
    J Health Serv Res Policy 12:95-100. 2007
    ....
  89. ncbi Medicare bad debts-take two
    Joanne B Erde
    Duane Morris, LLP, Miami, USA
    Healthc Financ Manage 62:24-5, 27. 2008
  90. ncbi Legal aspects of tissue banking
    Ulrich M Gassner
    Faculty of Law, University of Augsburg, Augsburg, Germany
    Pathobiology 74:270-4. 2007
    ..Consequently, anybody involved in tissue banking is well advised to observe the evolution of the legal and regulatory environment in the particular jurisdiction...
  91. ncbi Synthetic genomics | options for governance
    Michele S Garfinkel
    J. Craig Venter Institute, Rockville, Maryland, USA
    Biosecur Bioterror 5:359-62. 2007
  92. ncbi Orthopaedic joint devices: the FDA's short answers to your questions
    Jonette R Foy
    Orthopaedic Joint Devices Branch, Division of General, Restorative and Neurological Devices, Center for Devices and Radiological Health, US Food and Drug Administration, Rockville, MD, USA
    J Am Acad Orthop Surg 16:S123-8. 2008
    ..The FDA relies on accurate scientific evidence and regulatory science to determine the safety and effectiveness of orthopaedic joint devices...
  93. ncbi Re: Commercialism, choice and consumer protection: regulation of complementary medicines in Australia
    Nigel A Pollard
    Med J Aust 189:50-2; author reply 52-3. 2008
  94. ncbi Bureaucratic obstruction of conservation science in the Guayana Highlands
    Valentí Rull
    Conserv Biol 22:508-9. 2008
  95. ncbi "The mercury's rising!" Can national health group intervention protect the public health from EPA'S Clean Air Mercury Rule?
    James D Stivers
    Southern Illinois University School of Law, IL 62901, USA
    J Leg Med 27:323-40. 2006
  96. ncbi Practical and effective ALARA
    Joseph John Bevelacqua
    Bevelacqua Resources, 343 Adair Drive, Richland, WA 99352, USA
    Health Phys 98:S39-47. 2010
    ....
  97. ncbi Mandatory reporting of diseases and conditions by health care professionals and laboratories
    S Roush
    Council of State and Territorial Epidemiologists, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 282:164-70. 1999
    ..Systematic reporting by health care professionals and laboratories, which may vary by state law, statute, or regulation, continues to provide essential data for assessing public health...
  98. ncbi A European perspective on animal cloning and government regulation
    Cesare Galli
    Laboratorio di Tecnologie della Riproduzione, Consorzio per l'Incremento Zootecnico, Associazione Italiana Allevatori, Cremona, Italy
    IEEE Eng Med Biol Mag 23:52-4. 2004
  99. ncbi Where have all the young girls gone? Preconception gender selection in India and the United States
    Kenan Farrell
    Indiana University School of Law Indianapolis, USA
    Indiana Int Comp Law Rev 13:253-81. 2002
  100. ncbi New waiver of regulations on research with prisoner-subjects
    Dennis M Maloney
    The Deem Corporation, P.O. Box 44069, Omaha, NE 68144, USA
    Hum Res Rep 18:1-2. 2003
  101. ncbi Human gene therapy and slippery slope arguments
    T McGleenan
    School of Law, Queen s University of Belfast
    J Med Ethics 21:350-5. 1995
    ....

Research Grants161 found, 100 shown here

  1. Trends and Trajectories of Oral Health Among Older Americans: The Role of Cognit
    Bei Wu; Fiscal Year: 2009
    ..S. makes geriatric oral health an increasingly important public health issue that this study will address. This study will lead to the development of effective prevention and intervention strategies. ..
  2. Proxy Decision Making for Alzheimer Disease Research
    Laura Dunn; Fiscal Year: 2009
    ....
  3. Biology of Fungal Melanin
    Arturo Casadevall; Fiscal Year: 2009
    ..In this regard, a monoclonal antibody to fungal melanin made as part of this research program is already in clinical evaluation for the therapy of melanoma. ..
  4. Youth Alcohol, Tobacco and Marijuana Use: Effects of Hours of Work and Wages
    Robert Kaestner; Fiscal Year: 2009
    ..The proposed research will identify the importance of employment and earned income on youth substance use and produce information that can be used to design effective public health policy to address this problem. ..
  5. Synergy of Host Defense Mechanisms in the Lung
    Arturo Casadevall; Fiscal Year: 2009
    ..Furthermore, these studies will provide information that could be used to design vaccines and new therapies based on immunological reagents such as antibodies. ..
  6. Impact of Medicare Part D on Racial Disparities in Diabetes Treatment and Outcome
    Julie Marie Donohue; Fiscal Year: 2010
    ....
  7. Impact of Poor Health & AIDS on Small Businesses in SA
    Mark Pauly; Fiscal Year: 2003
    ..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
  8. National Black Leadership Conference on Genetics
    Kathy Hudson; Fiscal Year: 2004
    ..The Conference will be held in Washington DC in May 2004. ..
  9. Making Every Voice Count: Public Consultation on Genetics, Environment and Health
    Kathy Hudson; Fiscal Year: 2007
    ..abstract_text> ..
  10. Making Every Voice Count: Public Consultation on Genetics, Environment and Health
    Joan Scott; Fiscal Year: 2007
    ....
  11. NEWBORN GENETIC SCREENING:FOR WHOSE BENEFIT?
    Lainie Ross; Fiscal Year: 2005
    ..OUTCOMES: The major outcomes will be a series of peer-reviewed articles and a full-length book entitled Newborn Genetic Screening: In whose Interest? For whose Benefit? ..
  12. The Effect of Aflatoxin Regulation on Global Liver Cancer Risk
    Felicia Wu; Fiscal Year: 2010
    ..While we focus on the impact of a harmonized aflatoxin standard on global liver cancer burden, the methodologies can be broadened to address standard-setting of other important carcinogens. ..
  13. SYNERGY OF HOST DEFENSE MECHANISMS IN LUNG
    Arturo Casadevall; Fiscal Year: 2006
    ..By comparing the immune response in Ab-permissive and Ab-non-permissive murine strains we will learn the conditions and mechanisms by which Ab-mediates protection against C. neoformans. ..
  14. ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIA
    Alan Cohen; Fiscal Year: 2002
    ....
  15. Effects of Dioxin on Vietnamese Civilians
    David Carpenter; Fiscal Year: 2004
    ..7. ..
  16. Providers' perceptions of the diaphragm in Southern Afr*
    Cynthia Harper; Fiscal Year: 2005
    ..As the diaphragm effectiveness results become available, data from this proposed study will position us to design counseling interventions and to address provider education and training needs. ..
  17. NATIONAL RESEARCH SERVICE AWARD
    Vincent Mor; Fiscal Year: 2007
    ....
  18. Environmental Epidemiology in Community Settings
    David Ozonoff; Fiscal Year: 2007
    ..It also includes activities to enrich the experience of the trainees and promote social and professional cohesion. ..
  19. State Policies and Hospitalizations from Nursing Homes
    Vincent Mor; Fiscal Year: 2004
    ..These theoretical insights will help shape the policy implications emerging from the study. ..
  20. LONGITUDINAL ORAL HEALTH OUTCOMES IN HIGH-RISK ADULTS
    GREGG GILBERT; Fiscal Year: 2003
    ....
  21. Stem-Cell Based Tissue Engineering in Regenerative Medicine Conference
    Jeremy Mao; Fiscal Year: 2006
    ..abstract_text> ..
  22. Interventions for Tobacco Dependent Adolescents
    Dorothy Hatsukami; Fiscal Year: 2005
    ....
  23. Suicidality in Schizophrenia: Risk & Protective Factors
    DEQUINCY LEZINE; Fiscal Year: 2004
    ..abstract_text> ..
  24. ARE FEDERAL REGULATIONS ON ALCOHOL USE SAFE
    Jonathan Howland; Fiscal Year: 2001
    ..The results of this study will provide information on the risks of hangovers for injury and may inform public policy on alcohol use in conjunction with commercial ship operation. ..
  25. Tracking stem cells in engineered tissue and organs in vivo and in real time
    Jeremy J Mao; Fiscal Year: 2010
    ..It also has a potential to contribute to our understanding of the engineered osteochondral interface that is of critical value in bioengineered replacement of arthritic joints. ..
  26. OUTCOMES OF HOSPITAL STAFFING
    Linda Aiken; Fiscal Year: 1999
    ....
  27. SAFEHAVEN: Decision Support for Nursing Home Resident Disaster Evacuations
    Vincent Mor; Fiscal Year: 2010
    ..Using existing nursing home data from multiple sources, this study seeks to understand the consequences of hurricanes and evacuation decisions, providing the first evidence base to inform the creation of evacuation guidelines. ..
  28. FREE PLASMA SEX HORMONE AND ANDROGEN ACTION
    Robert Rosenfield; Fiscal Year: 1980
    ..The hypothesis that LH is insensitive to modest decrements of plasma testosterone will be tested by acutely lowering plasma testosterone levels in normal volunteers with aminoglutethimide...
  29. Community VOICES (2):Community VOICES on informed consent in emergency situations
    Lynne D Richardson; Fiscal Year: 2010
    ..The entire toolkit will be made publicly available on the Mount Sinai EM website and will be actively disseminated to medical societies, governmental agencies, bioethics organizations &others. ..
  30. SITE-SPECIFIC MUTAGENESIS OF ISOMERASES
    Gregory Petsko; Fiscal Year: 1990
    ..Finally, mutations will be made at several other positions where the crystallographic results and sequence conservation imply a possible role in either active site architecture or catalysis: Ser 96, Cys 126, Glu 97, and Asn 10...
  31. Stem Cell Based Soft Tissue Reconstruction
    Jeremy Mao; Fiscal Year: 2009
    ..An interdisciplinary team of biomedical engineers, biologists, biomaterial scientists, imaging scientists and surgical consultants have been assembled to meet the challenges of realizing our goals. ..
  32. Engineering of Vascularized Bone
    Jeremy J Mao; Fiscal Year: 2010
    ....
  33. Annotating functional sites in 3D biological structures
    RUSS BIAGIO ALTMAN; Fiscal Year: 2010
    ..In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites. ..
  34. Community VOICES (2):Community VOICES on informed consent in emergency situations
    Lynne Richardson; Fiscal Year: 2009
    ..The entire toolkit will be made publicly available on the Mount Sinai EM website and will be actively disseminated to medical societies, governmental agencies, bioethics organizations & others. ..
  35. PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS
    Arturo Casadevall; Fiscal Year: 2007
    ..neoformans and also to other efforts to develop Ab therapy, vaccines and fundamental immunology. ..
  36. Dental PBRN Network Chair
    GREGG GILBERT; Fiscal Year: 2006
    ..To our knowledge, we have more experience with dental practice-based research than any other team in the nation, which will enhance our anticipated success with the Dental PBRN. ..
  37. Biology of Fungal Melanin
    Arturo Casadevall; Fiscal Year: 2007
    ..It is anticipated that the work proposed here will provide important insights into the biology of melanin and in doing so highlight novel strategies for antimicrobial drug development. ..
  38. Mid-Career Investigator Award-Patient-Oriented Research
    GREGG GILBERT; Fiscal Year: 2005
    ....
  39. Impact of Changing Medicaid Policies on NH Quality
    Vincent Mor; Fiscal Year: 2006
    ..abstract_text> ..
  40. DEMOLITION AND ASTHMA IN CHICAGO PUBLIC HOUSING
    Samuel Dorevitch; Fiscal Year: 2006
    ....
  41. HOW NURSING AFFECTS THE VOLUME-OUTCOMES RELATIONSHIP
    Linda Aiken; Fiscal Year: 2003
    ....
  42. Welfare Reform, Fertility and Reproductive Behavior
    Robert Kaestner; Fiscal Year: 2003
    ....
  43. UAB Oral Health Research Infrastructure Improvement
    GREGG GILBERT; Fiscal Year: 2003
    ..abstract_text> ..
  44. Hospice Enrollment and LTC Policy (HELP)
    Susan Miller; Fiscal Year: 2007
    ....
  45. SAFEHAVEN: Decision Support for Nursing Home Resident Disaster Evacuations
    Vincent Mor; Fiscal Year: 2010
    ..Using existing nursing home data from multiple sources, this study seeks to understand the consequences of hurricanes and evacuation decisions, providing the first evidence base to inform the creation of evacuation guidelines. ..
  46. LONGITUDINAL ORAL HEALTH OUTCOMES IN HIGH-RISK ADULTS
    GREGG GILBERT; Fiscal Year: 2002
    ....
  47. A Comparative Study of International Law and Public Health Preparedness
    Rebecca Katz; Fiscal Year: 2007
    ..The project also addresses several sub-goals, including 'examining the impact of international health regulations on public health infrastructure,' and 'law as a cross cutting research tool. ..
  48. Xylitol Adult Caries Trial (X-ACT): UAB Clinical Center
    GREGG GILBERT; Fiscal Year: 2007
    ..Little research has been done on methods to prevent tooth decay in adults. This study would test how well a lozenge to be taken several times a day works to prevent tooth decay in adults who are prone to tooth decay. ..
  49. DO GOOD NURSING HOMES ACHIEVE GOOD OUTCOMES?
    Vincent Mor; Fiscal Year: 2003
    ..This latter exploratory data analysis step is crucial to derive from the theoretical results insights about how to intervene in a nursing home to improve the chance of achieving positive outcomes. ..